Key result
Pulmonary tumor thrombotic microangiopathy presents as rapidly progressive pulmonary hypertension and fatal RV failure.
Why the study?
Pulmonary tumor thrombotic microangiopathy is an under-recognized cause of pulmonary hypertension and fulminant right ventricular failure with high mortality due to delayed diagnosis.
Case Report (n=2)
PTTM is a near-fatal, under-recognized cause of pulmonary hypertension and right ventricular failure that requires timely identification.
PTTM warrants consideration in unexplained rapidly progressive PH with RV failure; case reports leave open prospective validation of antemortem diagnostics.
Pulmonary tumor thrombotic microangiopathy (PTTM) is an under-recognized cause of pulmonary hypertension and fulminant right ventricle failure. It is associated with a high mortality due to delay in diagnosis. We present two cases of PTTM, both diagnosed postmortem, highlighting the importance of timely identification and initiation of treatment for this near-fatal condition.
No takes yet. Share an insight, caveat, or question.
Ramakrishnan et al. (2023) conducted a case report in Pulmonary tumor thrombotic microangiopathy (PTTM) (n=2). Pulmonary tumor thrombotic microangiopathy was evaluated. Pulmonary tumor thrombotic microangiopathy presented as rapidly progressive pulmonary hypertension leading to fulminant right ventricle failure and death in two patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: